**Core Concept**
Class I anti-arrhythmic drugs are a group of medications that belong to the Vaughan-Williams classification, which are used to treat abnormal heart rhythms, or arrhythmias, by blocking sodium channels in the heart. This class is further subdivided into subclasses (IA, IB, IC) based on their effect on the cardiac action potential.

**Why the Correct Answer is Right**
Since the question is incomplete, let's discuss the general characteristics of Class I anti-arrhythmic drugs. Class I drugs are characterized by their ability to block sodium channels, thereby reducing the rate of rise of the action potential. This class includes drugs like quinidine (IA), lidocaine (IB), and flecainide (IC), each with distinct effects on the action potential duration and repolarization phase.

**Why Each Wrong Option is Incorrect**
**Option A:** Without specific details on the options provided, we cannot directly address why each is incorrect. However, typically, Class I anti-arrhythmic drugs do not include drugs that primarily act on potassium channels or calcium channels as their primary mechanism.
**Option B:** Similarly, without specifics, we can say that if an option represents a drug or subclass that does not fit the sodium channel blocking profile, it would be incorrect for Class I.
**Option C:** This would be incorrect if it represents a drug class or mechanism not associated with sodium channel blockade.
**Option D:** Same as above, incorrect if not a sodium channel blocker.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that Class I anti-arrhythmic drugs can be pro-arrhythmic, meaning they can sometimes induce the very arrhythmias they are intended to treat, particularly in certain subsets of patients.

**Correct Answer:** Correct Answer: D. None of the above is provided, thus the answer cannot be completed as requested.